Study of Combination Treatment Using Anlotinib and TQB2450 in Patients With Advanced Hepatocellular Carcinoma Who Failed Prior Immune Checkpoint Inhibitor Therapies: a Single Arm, Multicenter Clinical Trial
Latest Information Update: 13 Sep 2023
At a glance
- Drugs Benmelstobart (Primary) ; Catequentinib (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- Acronyms FAITH
- 13 Sep 2023 New trial record